Final Results of a CTEP Sponsored Phase I Study of Alistertib in Combination with Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma

Bibliographic Details
Title: Final Results of a CTEP Sponsored Phase I Study of Alistertib in Combination with Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma
Authors: Barta, Stefan Klaus, Kornblum, Noah *, Raphael, Bruce G., Hymes, Kenneth B., Grossbard, Michael L., Moskovits, Tibor, Handorf, Elizabeth *, Sparano, Joseph *, Piekarz, Richard *, Diefenbach, Catherine
Source: In Blood 29 November 2018 132 Supplement 1:4166-4166
Database: ScienceDirect
More Details
ISSN:00064971
DOI:10.1182/blood-2018-99-116991
Published in:Blood
Language:English